Thousand Oaks Biologics at CPHI Frankfurt 2025
Thousand Oaks Biologics, a leading Asia-based CRDMO, announced its participation in CPHI Frankfurt 2025, held from October 28-30.
The company will showcase its integrated service platform, including industrial media supply and AI-driven drug discovery technologies, at Booth 4.1H54 in the Bioproduction Zone.
Antibody-drug conjugates (ADCs) are a key driver of China's innovative drug globalization.
- Event: CPHI Frankfurt 2025
- Location: Booth 4.1H54, Bioproduction Zone
- Dates: October 28-30
Thousand Oaks Biologics is a trusted partner in the global biopharmaceutical ecosystem.
Author's summary: Thousand Oaks Biologics showcases ADC solutions at CPHI Frankfurt 2025.
More News
- What makes a scientific breakthrough truly chemical?
- Mariah The Scientist Honors Young Thug With “Cater 2 U” Performance At Birthday Bash
- While Mel Owens Hunts for Love on TV, His Ex-Wife Already Found It
- The children are starving; God is screaming – Baptist News Global
- Missouri Department of Conservation explains importance of managed deer hunts
- Illinois House Democrats push first-in-the-world wealth tax, streaming, concert taxes
- Will today’s Fed rate cut be last one until summer 2026? - Sharecafe
- DAC Companies Pivot on High Costs, Funding Cuts
- How to get the new Windows Start menu now
- This ‘impressive’ AI model predicted Hurricane Melissa’s perilous growth